Why Novavax, Orphazyme, Avenue Therapeutics Shares Are Moving Monday
Novavax, Inc. (NASDAQ: NVAX), Orphazyme A/S (NASDAQ: ORPH) and Avenue Therapeutics, Inc.
64 Biggest Movers From Friday
Gainers
Kanzhun Limited (NASDAQ: BZ) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share.
The Week Ahead In Biotech: Takeda, Blueprint Medicines, Orphazyme, Eton On The Radar Ahead Of FDA Decisions, IPOs
Biotech stocks extended their gains in the week ended June 11, supported by the broader market strength and some stock-specific moves.
46 Stocks Moving In Friday’s Mid-Day Session
Gainers
Kanzhun Limited (NASDAQ: BZ) shares surged 77.4% to $33.70 after the company priced its IPO at $19 per share.
Mid-Day Market Update: Markets Mixed; Novan Shares Spike Higher
Midway through trading Friday, the Dow traded down 0.07% to 34,442.46 while the NASDAQ rose 0.09% to 14,033.42. The S&P also rose, gaining 0.01% to 4,239.73.
The Daily Biotech Pulse: Vertex Shelves Mid-Stage Study, Precigen & Novan Jump On Data, Hematology Conference, Janux Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 10)
Benzinga Pro’s Top 5 Stocks To Watch For Friday, Jun. 11, 2021: BIIB, TTWO, KR, MEDS, ARMK
Today's 5 Stock Ideas
Biogen (BIIB) - Shares were upgraded to Outperform by a Bernstein analyst. The analyst set a $500 price target on Biogen shares. The new price target represented potential upside
28 Stocks Moving in Friday’s Pre-Market Session
Gainers
Amesite Inc. (NASDAQ: AMST) rose 138% to $6.60 in pre-market trading after surging over 25% on Thursday.
Orphazyme Announced Earlier it is Not Aware of Any Material Change in Its Clinical Development Programs, Financial Condition or Results of Operations That Would Explain Recent Price Volatility, Trading Volume
Orphazyme A/S (NASDAQ: ORPH), a late-stage biopharmaceutical company pioneering the heat shock protein response for the treatment of rare diseases, today announced that American Depositary Shares (ADSs) representing its ordinary shares on Nasdaq US have since June 10, 2021 experienced extreme volatility in price and trading vo
